WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2014> 25> 2

Volume: 25 Issue: 2

1. Book Review: Primary, secondary, and tertiary prevention of cervical cancer. Page:157—158
2. Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer. Page:155—155
3. Building a successful fertility preservation program at a major cancer center. Page:148—154
4. Adjuvant therapy for endometrial cancer. Page:136—147
5. Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer. Page:130—135
6. Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan. Page:124—129
7. Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women. Page:118—123
8. Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes. Page:111—117
9. Survival analysis of endometrial cancer patients with cervical stromal involvement. Page:105—110
10. Cost-utility analysis of treatments for stage IB cervical cancer. Page:97—104
11. The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer. Page:90—96
12. Creating and field-testing the questionnaire for the assessment of knowledge about cervical cancer and its prevention among schoolgirls and female students. Page:81—89
13. Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision. Page:79—80